Anesthetic Considerations for the HIV+ Patient. Veronica Y. Amos PhD CRNA October 2014. Prevalence. In 2011, an estimated 1.1 million persons in the U.S. were living with HIV infection 1 in 6 (15.8%) are unaware they are HIV positive. Incidence.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Anesthetic Considerations for the HIV+ Patient
Veronica Y. Amos PhD CRNA
Normal: 600 -1200 cells per cubic mm of blood
Meds not needed: 600-350
Increased risk: 350-200 (meds may be started)
Risk for opportunistic infections: less than 200
- Bronchitis, sinusitis, pneumonia (PCP)
- TB, myobacteria and fungal infections
- Airway obstruction (Kaposi’s sarcoma)
- Acute and chronic disease
Risk factors for vertical transmission include prolonged preterm rupture of membranes (>4 hrs), chorioamnionitis, presence of STD, lack of maternal antiviral therapy, and obstetrical invasive procedures such as cervical cerclage and amniocentesis